Aug 27 (Reuters) – The European Medicines Agency on Thursday disclosed a shortage of an injectable medicine used to treat schizophrenia in some member EU states due to issues at contract manufacturer
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Should you have designated ‘workout underwear’? Experts explain
We have trainers, leggings and sports bras designed specifically for exercise and sweating – but…
Socure valued at $5.2 billion in latest funding, buys Fravity
Aug 27 (Reuters) - Identity verification startup Socure raised $156 million in a series E…
Analysis-Bessent, Warsh diverge on who should set the price of money
By Karen Brettell Aug 27 (Reuters) - Treasury Secretary Scott Bessent and Federal Reserve Chairman…
